Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 3
Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease
This study is a non-randomized, open-label, multi-cohort, multi-site, pilot feasibility therapeutic trial. The study will enroll 20 patients across 4 cohorts (…
Colon AdenocarcinomaRectal AdenocarcinomaGastric Adenocarcinoma+4 more
Georgetown UniversityNCT05482516
Phase 2
Phase II Prospective, Open Label Randomized Controlled Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
This is a randomized, open label, single-center, phase 2, randomized controlled trial of sequential cytoreductive intervention versus standard of care therapy …
Foregut AdenocarcinomaEsophageal AdenocarcinomaGastroesophageal Adenocarcinoma+6 more
Yale UniversityNCT07282912
Phase 1
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Gallbladder adenocarcinoma is a devastating disease associated with a poor prognosis. Gallbladder and other biliary cancers will be responsible for an estimate…
Gallbladder Adenocarcinoma
West Virginia UniversityNCT05430035